Skip to content. | Skip to navigation

Personal tools

Sections

Managing bodies

logo Inserm      logo cnrslogo ENSL       logo ucb1


Secondary managing bodies

logo ENSL logo ucb1

You are here: Home

Search results

64 items matching your search terms.
Filter the results.
Item type

























New items since



Sort by relevance · date (newest first) · alphabetically
Evidence for long-term association of virion-delivered Hepatitis B virus Core protein with cccDNA independently of viral protein production
Lucifora, Pastor et al., JHep Reports, 2021 / Team HepVir
Located in Teams / Durantel D - HepVir / What's new for us?
Experience from five Asia-Pacific countries during the first wave of the COVID-19 pandemic: Mitigation strategies and epidemiology outcomes
Travel Med Infect Dis.
Located in Teams / Vanhems P - PHE3ID / Actualités
Farnesoid X receptor alpha ligands inhibit HDV in vitro replication and virion infectivity.
Legrand AF, Lucifora J, Lacombe B, Ménard C, Michelet M, Foca A, Abrial P, Salvetti A, Rivoire M, Lotteau V, Durantel D, André P, Ramière C. Hepatol Commun. 2023 Apr 14;7(5):e0078.
Located in Teams / VIDALAIN PO - VIRIMI / News
Farnesoid X receptor alpha ligands inhibit hepatitis delta virus in vitro replication and virion infectivity
Legrand, Lucifora et al., Hepatology Communications, 2023 / Team VIRIMI and Team HepVir
Located in Teams / Durantel D - HepVir / What's new for us?
Generation of a C57BL/6J mouse strain expressing the CD45.1 epitope to improve hematopoietic stem cell engraftment and adoptive cell transfer experiments
Laubreton D, Djebali S, Angleraux C, Chain B, Dubois M, Henry F, Leverrier Y, Teixeira M, Markossian S, Marvel J.
Located in Teams / Marvel J - ICL / Actualités
Identification of a novel antiviral factor that reorganises Microtubules
Trim69 is a microtubule regulator that acts as a pantropic viral inhibitor Yuxin Song, Xuan-Nhi Nguyen, Anuj Kumar, Claire da Silva, Léa Picard, Lucie Etienne and Andrea Cimarelli. Just published on PNAS https://doi.org/10.1073/pnas.2211467119
Located in Teams / Cimarelli A - LP2L / News
Immunogenicity and efficacy of heterologous ChAdOx1–BNT162b2 vaccination
Pozzeto et al. Nature. December 2021
Located in Teams / Paul S - GIMAP / Actualités
Inducers of the NF-κB pathways impair Hepatitis Delta virus (HDV) replication & strongly decrease progeny infectivity in vitro
Michelet, Alfaiate, Chardès et al., J Hep Reports, 2022 / Team HepVir
Located in Teams / Durantel D - HepVir / What's new for us?
Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against HBV
Lamrayat et al., Antiviral Research, 2023 / Team HepVir
Located in Teams / Durantel D - HepVir / What's new for us?
Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients
by X.Charmetant, M.Espi (...) and O.Thaunat, Science Translational Medicine 2022 DOI : 10.1126/scitranslmed.abl6141
Located in Teams / Thaunat O - NOPAB / Actualités